会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Therapeutic use of agonist ligands specific to G2A receptor
    • 治疗性使用对G2A受体特异性的激动剂配体
    • US07410955B2
    • 2008-08-12
    • US10509300
    • 2003-03-25
    • Yung-Hi KimDong-Keun SongHong-Won SuhSung-Oh Huh
    • Yung-Hi KimDong-Keun SongHong-Won SuhSung-Oh Huh
    • A61K31/665
    • A61K31/685A61K31/00Y02A50/40Y02A50/401
    • The present invention relates to novel therapeutical use of agonist ligands specific to G2A receptor. More particularly, the present invention relates to methods for treating a disease or disorder associated with neutrophil accumulation and hyperactivity and/or excessive release of IL-8, or with microbial infection, in a subject, comprising administering LPC (lysophosphatidylcholine), SPC(sphingophosphorylcholine) or derivatives thereof to the subject. The agonist ligands for G2A receptor according to the present invention and pharmaceutical- or therapeutical composition comprising said ligands can be used effectively in treatment of a disease or disorder associated with neutrophil accumulation and hyperactivity and/or excessive release of IL-8, specifically inflammatory diseases and diseases associated with ischemia-reperfusion injury as well as microbial infection.
    • 本发明涉及对G2A受体特异性的激动剂配体的新型治疗用途。 更具体地说,本发明涉及用于治疗受试者中嗜中性粒细胞积聚和多动症和/或IL-8或微生物感染过度释放的疾病或病症的方法,包括给予LPC(溶血磷脂酰胆碱),SPC(鞘磷脂酰胆碱 )或其衍生物。 根据本发明的用于G2A受体的激动剂配体和包含所述配体的药物或治疗组合物可以有效地用于治疗与嗜中性粒细胞积聚和多动症相关的疾病或病症和/或过度释放IL-8,特别是炎性疾病 以及与缺血再灌注损伤相关的疾病以及微生物感染。